246 related articles for article (PubMed ID: 21470282)
21. Glucagonoma syndrome.
Bloom SR; Polak JM
Am J Med; 1987 May; 82(5B):25-36. PubMed ID: 2884877
[TBL] [Abstract][Full Text] [Related]
22. Rare presentation of endocrine pancreatic tumour: a case of glucagonoma without necrolytic migratory erythema?
Manes G; Pellegrini A; Riccardi F; Uomo G
Ital J Gastroenterol; 1995 Jun; 27(5):248-9. PubMed ID: 8541575
[TBL] [Abstract][Full Text] [Related]
23. [Glucagonoma: evolution and treatment].
Carvajal C; Azabache V; Lobos P; Ibarra A
Rev Med Chil; 2002 Jun; 130(6):671-6. PubMed ID: 12194691
[TBL] [Abstract][Full Text] [Related]
24. Necrolytic Migratory Erythema: Complete Healing after Surgical Removal of Pancreatic Carcinoma.
V'lckova-Laskoska M; Balabanova-Stefanova M; Arsovska-Bezhoska I; Caca-Biljanovska N; Laskoski D
Acta Dermatovenerol Croat; 2018 Dec; 26(4):329-332. PubMed ID: 30665484
[TBL] [Abstract][Full Text] [Related]
25. [Clinical experience in diagnosis and treatment of glucagonoma].
Liu WJ; Zhao YP; Zhang TP; Liao Q; Cong L
Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(5):333-6. PubMed ID: 19595005
[TBL] [Abstract][Full Text] [Related]
26. Glucagonoma syndrome and necrolytic migratory erythema.
Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
[TBL] [Abstract][Full Text] [Related]
27. Neuropsychiatric symptoms, skin disease, and weight loss: necrolytic migratory erythema and a glucagonoma.
Boujan N; Géraud C
Lancet; 2020 Mar; 395(10228):985. PubMed ID: 32199485
[No Abstract] [Full Text] [Related]
28. Glucagonoma syndrome associated with necrolytic migratory erythema.
Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
[TBL] [Abstract][Full Text] [Related]
29. Spleen-preserving distal pancreatectomy and lymphadenectomy for glucagonoma syndrome: A case report.
Cao X; Wang X; Lu Y; Zhao B; Shi J; Guan Q; Zhang X
Medicine (Baltimore); 2019 Sep; 98(38):e17037. PubMed ID: 31567941
[TBL] [Abstract][Full Text] [Related]
30. Glucagonoma syndrome: survival 24 years following diagnosis.
Nightingale KJ; Davies MG; Kingsnorth AN
Dig Surg; 1999; 16(1):68-71. PubMed ID: 9949270
[TBL] [Abstract][Full Text] [Related]
31. [Glucagonoma: a recent series of 7 cases].
Vauleon E; Egreteau J; Boucher E; Desfourneaux V; Bretagne JF; Raoul JL
Bull Cancer; 2004; 91(7-8):637-40. PubMed ID: 15381454
[TBL] [Abstract][Full Text] [Related]
32. Metastatic glucagonoma: treatment with liver transplantation.
Radny P; Eigentler TK; Soennichsen K; Overkamp D; Raab HR; Viebahn R; Mueller-Horvart C; Sotlar K; Rassner G
J Am Acad Dermatol; 2006 Feb; 54(2):344-7. PubMed ID: 16443073
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide.
Oberkirchner U; Linder KE; Zadrozny L; Olivry T
Vet Dermatol; 2010 Oct; 21(5):510-6. PubMed ID: 20500495
[TBL] [Abstract][Full Text] [Related]
34. Rapid Clearance of Necrolytic Migratory Erythema Following Intravenous Administration of Amino Acids.
Thomaidou E; Nahmias A; Gilead L; Zlotogorski A; Ramot Y
JAMA Dermatol; 2016 Mar; 152(3):345-6. PubMed ID: 26581030
[No Abstract] [Full Text] [Related]
35. Clinical experience in diagnosis and treatment of glucagonoma syndrome.
Zhang M; Xu X; Shen Y; Hu ZH; Wu LM; Zheng SS
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):473-5. PubMed ID: 15313692
[TBL] [Abstract][Full Text] [Related]
36. Necrolytic migratory erythema: A diagnostic clue in glucagonoma syndrome.
Moreno-Suárez F; Pulpillo-Ruiz Á; Fontillón Alberdi M
Med Clin (Barc); 2017 Apr; 148(8):e45. PubMed ID: 27567335
[No Abstract] [Full Text] [Related]
37. Glucagonoma With Necrolytic Migratory Erythema: Metabolic Profile and Detection of Biallelic Inactivation of DAXX Gene.
Tamura A; Ogasawara T; Fujii Y; Kaneko H; Nakayama A; Higuchi S; Hashimoto N; Miyabayashi Y; Fujimoto M; Komai E; Kono T; Sakuma I; Nagano H; Suzuki S; Koide H; Yokote K; Iseki K; Oguma R; Matsue H; Nojima H; Sugiura K; Yoshitomi H; Ohtsuka M; Rahmutulla B; Kaneda A; Inoshita N; Ogawa S; Tanaka T
J Clin Endocrinol Metab; 2018 Jul; 103(7):2417-2423. PubMed ID: 29688432
[TBL] [Abstract][Full Text] [Related]
38. [Necrolytic migratory erythema revealing glucagonoma without diabetes].
Marty C; Bennet A; Bayle P; Danjoux M; Lalande T; Marguery MC; Bazex J
Ann Med Interne (Paris); 2003 Dec; 154(8):552-6. PubMed ID: 15037834
[TBL] [Abstract][Full Text] [Related]
39. Glucagonoma Syndrome: A Rare Paraneoplastic Disorder due to Neuroendocrine Tumor of the Pancreas.
Yusuf MA; Mehmood S; Iftikhar J; Saqib M; Siddique MZ; Imtiaz W
J Coll Physicians Surg Pak; 2022 Aug; 32(8):S147-S149. PubMed ID: 36210677
[TBL] [Abstract][Full Text] [Related]
40. [Glucagonoma without glucagonoma syndrome].
Colović R; Matić S; Micev M; Grubor N; Latincić S
Srp Arh Celok Lek; 2010; 138(3-4):244-7. PubMed ID: 20499510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
